Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Braveheart Bio, Inc.

News headline image
Hengrui Pharma and Braveheart Bio Present Data from 52-Week Open-Label Extension of Phase 2 Study of HRS/BHB-1893 in Obstructive Hypertrophic Cardiomyopathy at American Heart Association Scientific Sessions 2026
From Braveheart Bio, Inc.
Via GlobeNewswire
Tickers BRVE
News headline image
Braveheart Bio to Host Webinar – HCM Spotlight: Advancing a Next-Generation Cardiac Myosin Inhibitor – with Key Opinion Leader Discussion on November 6, 2026
From Braveheart Bio, Inc.
Via GlobeNewswire
Tickers BRVE
News headline image
Braveheart Bio Announces Upcoming Presentations at the American Heart Association Scientific Sessions 2026
From Braveheart Bio, Inc.
Via GlobeNewswire
Tickers BRVE
News headline image
Braveheart Bio to Participate in Stifel Cardiometabolic Forum
From Braveheart Bio, Inc.
Via GlobeNewswire
Tickers BRVE
News headline image
Braveheart Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
From Braveheart Bio, Inc.
Via GlobeNewswire
Tickers BRVE
News headline image
Braveheart Bio to Participate in Cantor Global Healthcare Conference
From Braveheart Bio, Inc.
Via GlobeNewswire
Tickers BRVE
News headline image
Braveheart Bio Announces Closing of Upsized Initial Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
From Braveheart Bio, Inc.
Via GlobeNewswire
Tickers BRVE
News headline image
Braveheart Bio Announces Pricing of Upsized Initial Public Offering
From Braveheart Bio, Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.